Peginterferon alfa-2a

Basic Information


CAS ID: 198153-51-4
Molecular Formula:
Molecular Weight: g/mol
Monoisotopic Mass: g/mol
Class: Protein based biotech
Natural Product: No
Other Names: PEGASYS | RO 25-8310/000 | ROFERON-A | PEGINTERFERON ALFA-2A
Analysis: N/A


Compound Structure and Identifier


InChI: See All
InChI Key:
Smiles: See All
Molfile:


Related Target



Related Fibrosis Property


Trial Record 1

ClinicalTrial ID NCT01634919 Disease Liver fibrosis
Phase Status Unknown
First Received July 6, 2012 Last Verified October 11, 2017
Sponsor Seoul National University Boramae Hospital

Trial Record 2

ClinicalTrial ID NCT00006164 Disease Liver fibrosis
Phase Phase 3 Status Completed
First Received August 9, 2000 Last Verified May 11, 2018
Sponsor National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Trial Record 3

ClinicalTrial ID NCT00442572 Disease Liver fibrosis
Phase Phase 2 Status Completed
First Received March 2, 2007 Last Verified April 6, 2017
Sponsor Hoffmann-La Roche

Trial Record 4

ClinicalTrial ID NCT01006031 Disease Liver fibrosis
Phase Phase 2,Phase 3 Status Completed
First Received November 2, 2009 Last Verified December 30, 2011
Sponsor Sociedad Andaluza de Enfermedades Infecciosas

Trial Record 5

ClinicalTrial ID NCT00304551 Disease Liver fibrosis
Phase Phase 3 Status Completed
First Received March 20, 2006 Last Verified June 3, 2010
Sponsor Chugai Pharmaceutical

Trial Record 6

ClinicalTrial ID NCT01888900 Disease Liver fibrosis
Phase Phase 2 Status Completed
First Received June 28, 2013 Last Verified February 7, 2017
Sponsor National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related Link


PubChem: 47205819
ChEMBL: CHEMBL1201560